0001140361-13-012910.txt : 20130318 0001140361-13-012910.hdr.sgml : 20130318 20130318140838 ACCESSION NUMBER: 0001140361-13-012910 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130314 FILED AS OF DATE: 20130318 DATE AS OF CHANGE: 20130318 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Abdun-Nabi Daniel CENTRAL INDEX KEY: 0001380187 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33137 FILM NUMBER: 13697071 MAIL ADDRESS: STREET 1: 2273 RESEARCH BLVD, SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Emergent BioSolutions Inc. CENTRAL INDEX KEY: 0001367644 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 141902018 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2273 RESEARCH BLVD, SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: (301) 795-1800 MAIL ADDRESS: STREET 1: 2273 RESEARCH BLVD, SUITE 400 CITY: ROCKVILLE STATE: MD ZIP: 20850 4 1 doc1.xml FORM 4 X0306 4 2013-03-14 0 0001367644 Emergent BioSolutions Inc. EBS 0001380187 Abdun-Nabi Daniel 2273 RESEARCH BLVD. SUITE 400 ROCKVILLE MD 20850 1 1 0 0 CEO & President Common Stock 2013-03-14 4 F 0 2248 14.46 D 95211 D Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan. /s/Jay G. Reilly, attorney-in-fact 2013-03-18